Literature DB >> 2491009

The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

M Koenig1, A H Beggs, M Moyer, S Scherpf, K Heindrich, T Bettecken, G Meng, C R Müller, M Lindlöf, H Kaariainen, A de la Chapellet, A Kiuru, M L Savontaus, H Gilgenkrantz, D Récan, J Chelly, J C Kaplan, A E Covone, N Archidiacono, G Romeo, S Liechti-Gailati, V Schneider, S Braga, H Moser, B T Darras, P Murphy, U Francke, J D Chen, G Morgan, M Denton, C R Greenberg, K Wrogemann, L A Blonden, M B van Paassen, G J van Ommen, L M Kunkel.   

Abstract

About 60% of both Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) is due to deletions of the dystrophin gene. For cases with a deletion mutation, the "reading frame" hypothesis predicts that BMD patients produce a semifunctional, internally deleted dystrophin protein, whereas DMD patients produce a severely truncated protein that would be unstable. To test the validity of this theory, we analyzed 258 independent deletions at the DMD/BMD locus. The correlation between phenotype and type of deletion mutation is in agreement with the "reading frame" theory in 92% of cases and is of diagnostic and prognostic significance. The distribution and frequency of deletions spanning the entire locus suggests that many "in-frame" deletions of the dystrophin gene are not detected because the individuals bearing them are either asymptomatic or exhibit non-DMD/non-BMD clinical features.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2491009      PMCID: PMC1683519     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

2.  A 10-megabase physical map of human Xp21, including the Duchenne muscular dystrophy gene.

Authors:  M Burmeister; A P Monaco; E F Gillard; G J van Ommen; N A Affara; M A Ferguson-Smith; L M Kunkel; H Lehrach
Journal:  Genomics       Date:  1988-04       Impact factor: 5.736

3.  Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy.

Authors:  A P Monaco; C J Bertelson; C Colletti-Feener; L M Kunkel
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

4.  A cDNA clone from the Duchenne/Becker muscular dystrophy gene.

Authors:  A H Burghes; C Logan; X Hu; B Belfall; R G Worton; P N Ray
Journal:  Nature       Date:  1987 Jul 30-Aug 5       Impact factor: 49.962

5.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

6.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein.

Authors:  M Koenig; A P Monaco; L M Kunkel
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

7.  Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy.

Authors:  E P Hoffman; K H Fischbeck; R H Brown; M Johnson; R Medori; J D Loike; J B Harris; R Waterston; M Brooke; L Specht
Journal:  N Engl J Med       Date:  1988-05-26       Impact factor: 91.245

8.  Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy.

Authors:  S M Forrest; T J Smith; G S Cross; A P Read; N S Thomas; R C Mountford; P S Harper; R T Geirsson; K E Davies
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

9.  Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker.

Authors:  G J van Ommen; C Bertelson; H B Ginjaar; J T den Dunnen; E Bakker; J Chelly; M Matton; A J van Essen; J Bartley; L M Kunkel
Journal:  Genomics       Date:  1987-12       Impact factor: 5.736

10.  An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.

Authors:  A P Monaco; C J Bertelson; S Liechti-Gallati; H Moser; L M Kunkel
Journal:  Genomics       Date:  1988-01       Impact factor: 5.736

View more
  293 in total

1.  ERG phenotype of a dystrophin mutation in heterozygous female carriers of Duchenne muscular dystrophy.

Authors:  K M Fitzgerald; G W Cibis; A H Gettel; R Rinaldi; D J Harris; R A White
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

2.  Novel mini-dystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma.

Authors:  Yadong Zhang; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2011-10-24       Impact factor: 5.695

3.  Monoclonal antibodies for dystrophin analysis. Epitope mapping and improved binding to SDS-treated muscle sections.

Authors:  T M Nguyen; I B Ginjaar; G J van Ommen; G E Morris
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

Review 4.  Molecular biology of neurological diseases.

Authors:  W J Cumming
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

5.  Quantitative Southern blot analysis in the dystrophin gene of Japanese patients with Duchenne or Becker muscular dystrophy: a high frequency of duplications.

Authors:  Y Hiraishi; S Kato; T Ishihara; T Takano
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

Review 6.  Recent advances in understanding muscular dystrophy.

Authors:  K M Bushby
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

7.  Extended electrophoresis resolves the dystrophin gene 5.2-kbp cDMD4-5a/HindIII fragment into two bands.

Authors:  Y M Otto; P G Rothberg
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

8.  Full-length dystrophin reconstitution with adeno-associated viral vectors.

Authors:  William Lostal; Kasun Kodippili; Yongping Yue; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2014-03-31       Impact factor: 5.695

9.  Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense.

Authors:  Annemieke Aartsma-Rus; Anneke A M Janson; Wendy E Kaman; Mattie Bremmer-Bout; Gert-Jan B van Ommen; Johan T den Dunnen; Judith C T van Deutekom
Journal:  Am J Hum Genet       Date:  2003-12-16       Impact factor: 11.025

10.  Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers.

Authors:  Eugene J Wyatt; Alexis R Demonbreun; Ellis Y Kim; Megan J Puckelwartz; Andy H Vo; Lisa M Dellefave-Castillo; Quan Q Gao; Mariz Vainzof; Rita C M Pavanello; Mayana Zatz; Elizabeth M McNally
Journal:  JCI Insight       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.